To dissect the role of EGFR in OA-induced KRASm/p53m CRC metastasis, the EGFR/KRAS downstream signaling pathways, such as ERK and AKT, were examined in EGF-treated and EGFR TKI-treated cells. The gene discussed is KRAS; the disease is colorectal carcinoma.